Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ajanta Pharma Ajanta Pharma Ltd. | BSE 2525.00 -22.80 (-0.89%) | NSE 2523.20 -25.80 (-1.01%) | Trade | Add

BSE Live

Nov 14, 16:01

2525.00 -22.80 (-0.89%)

Volume

AVERAGE VOLUME

5-Day

2,077

10-Day

4,095

30-Day

3,104

1,600

Prev. Close

2547.80
Open Price

2540.05

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 14, 15:55

2523.20 -25.80 (-1.01%)

Volume

AVERAGE VOLUME

5-Day

66,169

10-Day

112,723

30-Day

116,664

136,610

Prev. Close

2549.00
Open Price

2540.00

Bid Price (Qty.)
2523.20 (5)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ajanta Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.07	25.27	25.27	17.17	17.39
Total Share Capital	25.07	25.27	25.27	17.17	17.39
Reserves and Surplus	3,765.22	3,536.44	3,362.38	3,247.17	2,978.24
Total Reserves and Surplus	3,765.22	3,536.44	3,362.38	3,247.17	2,978.24
Total Shareholders Funds	3,790.29	3,567.36	3,387.99	3,264.34	2,995.63
Minority Interest	0.00	0.00	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	1.25	1.64	1.60
Deferred Tax Liabilities [Net]	110.52	108.50	97.72	101.87	92.17
Other Long Term Liabilities	37.77	27.23	28.63	21.02	22.76
Long Term Provisions	80.27	39.54	24.15	19.32	17.93
Total Non-Current Liabilities	228.56	175.27	151.75	143.85	134.46
CURRENT LIABILITIES
Short Term Borrowings	2.59	1.49	0.18	0.27	0.00
Trade Payables	454.20	463.20	422.77	327.17	373.86
Other Current Liabilities	515.96	413.31	702.31	309.14	263.06
Short Term Provisions	23.35	17.76	14.02	10.81	11.71
Total Current Liabilities	996.10	895.76	1,139.28	647.39	648.63
Total Capital And Liabilities	5,014.95	4,638.39	4,679.02	4,055.58	3,778.72
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,715.50	1,464.53	1,488.69	1,502.97	1,530.32
Intangible Assets	46.52	14.66	7.75	9.02	10.79
Capital Work-In-Progress	176.27	256.45	209.47	152.86	108.19
Fixed Assets	1,938.29	1,735.64	1,705.91	1,664.85	1,649.30
Non-Current Investments	25.24	18.58	25.10	25.10	0.00
Deferred Tax Assets [Net]	186.43	134.45	96.77	55.55	50.10
Long Term Loans And Advances	0.00	0.00	0.00	0.00	6.47
Other Non-Current Assets	21.96	18.80	17.24	45.62	45.26
Total Non-Current Assets	2,171.92	1,907.47	1,845.02	1,791.12	1,751.13
CURRENT ASSETS
Current Investments	438.71	330.05	510.27	121.86	175.67
Inventories	903.85	828.36	815.63	791.07	766.47
Trade Receivables	1,182.74	1,246.84	1,056.90	1,019.81	738.43
Cash And Cash Equivalents	176.24	130.77	330.90	211.79	209.61
Short Term Loans And Advances	2.54	33.96	17.39	6.37	8.03
OtherCurrentAssets	138.95	160.94	102.91	113.56	129.38
Total Current Assets	2,843.03	2,730.92	2,834.00	2,264.46	2,027.59
Total Assets	5,014.95	4,638.39	4,679.02	4,055.58	3,778.72
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	144.28	161.39	91.52	76.44	168.98
BONUS DETAILS
Bonus Equity Share Capital	15.50	15.63	15.63	7.09	7.09
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	25.24	18.58	0.00	0.00	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	428.59	299.15	510.27	121.86	138.99
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	36.68